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A B S T R A C T
Purpose: The prognosis of rolandic epilepsy (RE) is considered favorable. Since a moderate proportion of
cases presents with isolated seizures, continuous treatment should be considered only for frequent
seizures. Clinical and electroencephalogram (EEG) markers to predict seizure recurrence need to be
identiﬁed. The purpose of this study was to identify EEG criteria related to seizure recurrence in RE.
Methods: There were 10 children (aged 3–10 years; 6 males, 4 females) in the recurrence group and 12
(aged 4–7 years; 6 males, 6 females) in the isolated group. Occurrences of the number of spikes were
scored, and the presence of rolandic discharges (RD) in the awake record was evaluated. All patients were
evaluated longitudinally, clinically and by EEG, with repeated EEG recordings every 3 months. Clinical
and EEG follow-up was performed for 4 years.
Results: Seizure recurrence and extended periods of high-frequency paroxysmal EEG abnormalities
(>6 months after onset) were signiﬁcantly correlated (p < 0.001). Moreover, the appearance of RD in
awake recordings tended to be more prevalent in the recurrence group than in the isolated group
(odds ratio 4.714).
Conclusion: In addition to RD in the awake record, a combination of spike rate and extended periods of
high-frequency paroxysmal EEG abnormalities may predict seizure recurrence in RE.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Rolandic epilepsy (RE) is the most common idiopathic, age-
speciﬁc, epilepsy syndrome of childhood, with an estimated
prevalence of 20–25% in school children with epilepsy.1,2 RE is a
sleep-related disorder, and attacks occur predominantly during
sleep. Seizures during waking hours are more likely to occur
shortly after awakening.3 In general, RE is associated with a
favorable prognosis. Seizure frequency is usually low, and around
10% of cases has only one seizure (isolated seizure).2 Accordingly,
continuous treatment should be considered only in patients with
frequent seizures and when the ictal events are disruptive to the
patient or family. However, prognostic factors for seizure
recurrence remain unclear.4
Interictal epileptiform discharges on electroencephalogram
(EEG) are regarded as correlated with persistent pathological* Corresponding author at: Department of Pediatrics, Faculty of Medicine,
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1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reneuronal discharges.5 Early descriptions suggested that children
with rolandic spikes might be at risk for minor behavioral
disturbances or learning difﬁculties.6 Atypical cases sometimes
occur as a particular syndrome that shares features with other
recognized entities or has an unexpected evolution. However, with
regard to the frequency of paroxysmal EEG abnormalities and
the correlation with cognitive deﬁcits, the association of more
frequent discharges or multifocal paroxysms with complicated
evolution in RE is a debated subject.1,7,8 In contrast, in our
preliminary study, signiﬁcant correlations were found between
atypical clinical features and extended periods of high-frequency
paroxysmal EEG abnormalities in these atypical cases.9 In another
study by Bakke et al., interictal EEG abnormalities were associated
with behavioral problems.10 Moreover, our recent research
showed a signiﬁcant correlation between spike frequency in the
frontal region and behavioral problems.11 Thus, there is continued
debate about the importance of paroxysmal EEG abnormalities
and their relationships with clinical manifestations such as
seizure recurrence and behavioral problems.
Clinical and EEG markers to predict seizure recurrence need to
be identiﬁed. The purpose of the present study was to determine
the EEG criteria related to seizure recurrence in children with RE.served.
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2.1. Participants
A total of 22 patients with normal neurological examinations
and brain magnetic resonance imaging (MRI) was followed-up.
All children had experienced their index seizure between April 1,
2001 and March 31, 2006. Patients were referred to us from
the pediatric departments of University of Yamanashi Hospital
and its satellite hospitals. All children were suspected as
having RE at the ﬁrst evaluation. However, the clinical course
for some patients diverged from those of others. Some patients
demonstrated no seizure recurrence during the follow-up period.
Therefore, patients were divided into two groups according to
their clinical presentation (Table 1). The recurrence group
consisted of children who suffered from typical RE, and the
isolated group consisted of children without seizure recurrence.
All children in this study were enrolled within 1 week after
the appearance of their ﬁrst seizure. To be included in this study,
children (onset of seizures ranging from 3 to 14 years of age)
had to have normal neurologic and neuroradiologic examina-
tions. The exclusion criteria were as follows: concomitant
neurologic or psychiatric disorders, neurosurgical operation,
neurologic medication other than anti-epileptic drugs (AEDs),
combination therapy (two or more AEDs), and/or an IQ less
than or equal to 70. Patients with Fragile X syndrome were
also excluded.
2.1.1. The recurrence group
This group consisted of 10 children ranging in age from 3 to 10
years (mean age, 5.5 years; 6 males, 4 females). All patients
demonstrated the typical EEG abnormalities of this condition with
normal neurological examinations, and they fulﬁlled the following
criteria of typical RE2: (1) nocturnal partial seizures associated
with centrotemporal spikes on EEG; (2) onset of seizures ranging
from 3 to 14 years of age; (3) normal routine laboratory
examination and normal results on screening for metabolic
diseases (blood gas, lactate, pyruvate, and amino acid analyses);
(4) normal brain MRI; and (5) absence of other types of unprovoked
seizures. All patients were treated with antiepileptic drugs such as
carbamazepine (CBZ) after their third seizures (2–6 months after
seizure onset). All participants began therapy with CBZ, and one
participant was switched to sodium valproate (VPA) because of a
CBZ-related skin rash. Accordingly, nine children were treated by
CBZ (mean dose, 6.3 mg/kg/day; mean trough concentration,
4.2 mg/mL) and one was treated by VPA (dose, 11.4 mg/kg/day;
trough concentration, 48.8 mg/mL). The start of therapy was not
related to deterioration in the EEG.Table 1
Clinical proﬁles of the isolated and RE groups.
Recurrence
group (n = 10)
Isolated
group (n = 12)
Sex M:F = 6:4 M:F = 6:6
Age at seizure onset 5 y 0 mo 4 y 10 mo
Family history of
febrile seizure
3/10 (30%) 2/12 (16.7%)




Seizure type PS:SG = 8:2 PS:SG = 10:2
Seizure lateralization Rt:Lt:Bil = 4:4:2 Rt:Lt:Bil = 4:6:2
Seizure duration (>5 min) 0 0
Laterality of spike foci Rt:Lt:Bil = 3:4:3 Rt:Lt:Bil = 4:5:3
Comorbidities 0 0
M, male; F, female; PS, partial sensorimotor; SG, secondary generalization; Rt, right;
Lt, left; Bil, bilateral.2.1.2. The isolated group
This group consisted of 12 children ranging in age from 4 to 7
years (mean age, 5.3 years; 6 males, 6 females). All patients fulﬁlled
the above-mentioned criteria for RE. Accordingly, it was initially
impossible to differentiate these patients from those in the
recurrence group. None were given any treatment such as AEDs.
All patients had no seizure recurrence.
2.2. Assessment of interictal EEG abnormalities
Assessment of interictal EEG abnormalities has been described
in our previous report.9 A brief outline of the assessment
is provided. The EEGs were recorded without sedation for 20–
40 min using a digital system with the international 10–20 array
of electrode placement. All EEGs in this study were recorded
during both awake and sleep states. Three minutes of hyperven-
tilation and intermittent photic stimulation in wakefulness
were performed during each EEG recording session in all patients.
The EEG readers were blinded to the clinical details and groupings.
Two child neurologists analyzed EEG recordings with the words
‘‘rolandic,’’ ‘‘central,’’ ‘‘centrotemporal,’’ or ‘‘centro-temporal.’’
The EEG reports chosen for analysis were solely those for which
two child neurologists agreed that the EEG ﬁndings showed RE. In
addition, the dominant region was deﬁned by the localization of
spikes in cases where spikes were more frequent and higher in
amplitude. The occurrence of spikes in both the awake and
sleep states was scored as follows: (1) the number of spikes with
bipolar montage; (2) the localization of spikes, especially the term
for frontal EEG focus; and (3) the duration of spike activity. The
highest number of spikes from each state was used. The number of
spikes was greater in sleep stages 1 and 2 than in the awake state.
Accordingly, the rates of discharges were computed in sleep
stages 1 and 2 and expressed as the number of discharges per
minute. In addition, the presence of spikes in the awake state was
also evaluated. These evaluations were made by visual inspection.
The spikes were quantiﬁed by the same EEG readers. Moreover,
EEG readers quantiﬁed the spikes in the same EEG recording at
least twice, and conﬁrmed the data as intra-rater and inter-rater
reliabilities.
EEG recordings were started within 8–14 days after the
patients’ ﬁrst seizures in all patients. Accordingly, EEG recordings
were obtained in the recurrence group before CBZ treatment. All
patients were evaluated longitudinally, clinically and by EEG.
Repeated EEG recordings were obtained for all patients every 3
months. EEG follow-up was performed for at least 4 years for all
patients, and all patients were re-evaluated at the end of follow-up.
All EEG recordings from all patients in both groups were analyzed.
2.3. Seizure frequency and type
Clinical proﬁles such as seizure frequency and type were
evaluated. All patients were reviewed, and the results were
unanimously agreed by all authors. Clinical follow-up for at least 4
years was performed for all patients, and all patients were re-
evaluated at the end of follow-up.
2.4. The neuropsychological evaluations
The Wechsler Intelligence Scale for Children version III (WISC-
III) or the Wechsler Preschool and Primary Scale of Intelligence
(WPPSI) was evaluated by age in all patients at the onset of seizures
and every year.
2.5. Statistical methods
Statistical analysis was done using SPSS, version 19 (IBM, New
York, NY, USA). All data are presented as means of each measure.
Table 2








Isolated group (n = 12) 1 11
Recurrence group (n = 10) 3 7 4.714 0.405–548.28
CI, conﬁdence interval.
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using Fisher’s exact test, repeated ANOVA, Dunnett’s test, and
Student’s t-test, as appropriate. A p-value < 0.05 was deﬁned as
signiﬁcant.
2.6. Ethics committee and informed consent
Approval from our local ethics committee was obtained for
this research. Written, informed consent was obtained from the
parents of each patient following a full explanation of the
procedures to be performed.
3. Results
Mean follow-up durations of the recurrence and isolated
groups were 4.8 years and 4.3 years, respectively. Clinical proﬁles
of the isolated and recurrence groups are summarized in Table 1.
No children had either developmental delay or focal neurological
deﬁcits. In this series of patients, there were no differences in age
at seizure onset, developmental and previous febrile seizure (FS)
history, family history of epilepsy, or laterality of spike foci
between the two groups. Only family history of FS tended to be
higher in the recurrence group, but not signiﬁcantly (p = 0.62).
Antiepileptic treatment was administered to children in the
recurrence group. The mean interval between the ﬁrst and third
seizure in the recurrence group was 3.9 months. In nine patients in
the recurrence group, seizures disappeared 3 weeks after the onset
of therapy. In one patient in the recurrence group, seizures
disappeared 7 weeks after the onset of therapy. In addition, no
oromotor symptoms were observed in the recurrence and isolated
groups. Moreover, cognitive decline or behavioral problems such
as hyperactivity and impulsiveness were not seen in both groups.
Serial changes of spike frequency were less in the awake state
than in the sleep state. Accordingly, the number of spikes was
evaluated mainly in the sleep state, and only the presence of spikes
was evaluated in the awake state. In sleep stages 1–2, the
appearance of spikes in the recurrence group patients was initially
28 times/min on average. In contrast, the average rate of spikes
in the isolated group patients was initially 22 times/min. Interictal
EEG abnormalities clearly increased during the ﬁrst year in the
recurrence group. Spike rates increased from 28/min to 63/min.
In contrast, interictal EEG abnormalities increased slightly during
the ﬁrst 6 months in the isolated group. Spike rates increased
from 22/min to 27/min (Fig. 1). In the recurrence group, spike
rates were signiﬁcantly increased between 6 and 27 months after
onset (Dunnett’s test; p < 0.01 vs. baseline). In contrast, in theFig. 1. Serial changes in the appearance of paroxysmal discharges in sleep stage 1
and 2 records. The mean frequency (times/min) of rolandic discharges is plotted for
the recurrence group (open circles) and the isolated group (ﬁlled diamonds).isolated group, spike rates increased signiﬁcantly only 6 months
after onset (Dunnett’s test; p < 0.01 vs. baseline). In the recurrence
group, a high frequency of paroxysmal EEG abnormalities persisted
longer than in the isolated group. Finally, the spike rates for the
whole follow-up period were signiﬁcantly higher in the recurrence
group than in the isolated group (repeated ANOVA; p < 0.001).
The appearance of rolandic spikes in the awake recordings
differed between the recurrence and isolated groups. The
appearance rates in the recurrence and isolated groups
were 30% (3/10) and 8.3% (1/12), respectively (Table 2). The
appearance of rolandic spikes in awake recordings tended to be
more prevalent in the recurrence group than in the isolated group
(odds ratio: 4.714, conﬁdence interval: 0.405–548.28). The highest
number of spikes per minute in the awake state in the recurrence
and isolated groups was 4.3 (mean of three patients) and 4,
respectively. All four patients with spikes had the same frequency.
In addition, no patients in both groups had frontal EEG foci at
seizure onset. However, serial EEGs showed that the EEG focus
was in the frontal region (frontal EEG focus having a separate
frontal negative spike) in 70% (7/10) of the recurrence group
and 16.7% (2/12) of the isolated group, with mean durations of 4.3
months and 4.5 months, respectively. The EEG focus was present in
the frontal region signiﬁcantly more often in the recurrence group
than in the isolated group (Fisher’s exact test; p < 0.03), but
showed no signiﬁcant difference in duration (Student’s t-test;
p = 0.88). Atypical EEG manifestations, such as electrical status
epilepticus during slow sleep (ESES), were never present during
the follow-up period in both groups.
Cognitive function of recurrence group participants was within
the normal range (mean full IQ, 98 at onset; 99 at ﬁnal evaluation).
Similarly, cognitive function of isolated group participants was
within the normal range (mean full IQ, 97 at onset; 95 at ﬁnal
evaluation). In addition, serial changes of the mean full IQ on the
WISC-III or WPPSI were not different between the recurrence
group and the isolated group. Accordingly, no patients showed
any neuropsychological problems during the follow-up period
in both groups.
Anti-epileptic drugs such as CBZ can induce EEG deterioration.
However, EEG abnormalities seen in this study never showed
frequent widespread bilateral synchronous discharges. In addition,
spike rates increased from 27/min to 66/min in the one patient
treated by VPA. The spike frequency did not decrease in the patient
treated by VPA, similar to patients treated by CBZ. The possibility of
results being affected by CBZ in other cases could not be totally
ruled out, however, the effect of CBZ cannot account for the
worsening of the EEG in this study.
4. Discussion
The present study showed that seizure recurrence and
extended periods of high-frequency paroxysmal EEG abnormali-
ties (>6 months after onset) were signiﬁcantly correlated in
patients with RE. Moreover, the appearance of RD in awake
recordings tended to be more prevalent in the recurrence
group than in the isolated group.
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and EEG features of RE. In addition, the 10 patients in the
recurrence group never transitioned to more serious seizure
manifestations, such as atypical absences, negative myoclonus,
and diurnal seizures with impairments in cognitive functions and
behavior that harmed their quality of life thereafter. Furthermore,
atypical EEG manifestations such as ESES and extended frontal EEG
focus were never present during the follow-up period in both
groups.
With regard to the frequency of interictal epileptiform activity
and the correlation with atypical manifestations such as more
serious seizure manifestations and cognitive/behavioral impair-
ments, the association of more frequent discharges or multifocal
paroxysms with complicated evolution in RE is a debated subject.7
Extreme discrepancies between the rarity of seizures and the
activity of the EEG foci are not uncommon, and clinical experience
indicates that the EEG is often relatively unchanged, even with
effective treatment.12 In contrast, in patients presenting with
atypical clinical manifestations such as oromotor deﬁcits, the
number of spikes was most numerous during the period of
maximal drooling on the one hand, and spike frequency was
markedly reduced when drooling disappeared on the other hand.13
These ﬁndings suggest that oromotor deﬁcits such as drooling may
be caused by increased interictal spike activity as part of an
inhibitory mechanism affecting the functions of the lower motor
strip.14 Thus, clinical manifestations including seizure activity in
RE patients may be correlated with increased frequency of interictal
spike activity. The present results showed that spike rates were
higher in the recurrence group than in the isolated group. Moreover,
a high frequency of EEG abnormalities was seen over long periods in
the recurrence group. In another study by Verrotti et al., children
with atypical RE demonstrated persistent EEG abnormalities
compared with typical RE.15 These ﬁndings indicate that seizure
activity was accompanied by a marked increase in spike activity,
consistent with previous reports.7,9,16 A combination of spike rate
and extended periods of high frequency of paroxysmal EEG
abnormalities may predict seizure recurrence in RE.
Rolandic spike rates increase in drowsiness and in all stages of
sleep. In many children, rolandic spikes are found only in the sleep
portion. However, the appearance of rolandic spikes recorded
during the awake state differed between the recurrence and the
isolated groups in the present study. The abundance of awake
interictal abnormalities showed a trend toward a higher risk for
developing atypical clinical features such as frequent seizures.9
These ﬁndings suggest that the presence of paroxysmal discharges
in the awake state may be correlated with seizure recurrence. In
addition, Weglage et al. correlated IQ deﬁcits with greater than
6 spikes/min in the awake EEG; children with 5 spikes or less
had no deﬁcits.17 Moreover, Staden et al. found language
dysfunction in 13/20 children and correlated this with greater
than 10 spikes/min,18 with improvement after resolution of
spikes.19 Thus, the presence of paroxysmal discharges in the
awake state combined with a high frequency of spikes may be
correlated with atypical evolution for RE. In contrast, the present
study showed that WISC-III and WPPSI scores were not different
between the group with recurrent seizures and that with isolated
seizures, though spikes were frequently seen during the awake
state in the recurrent seizure group. The patients in the recurrence
group showed spikes during the awake state, with 5 spikes or less.
This may be the reason why cognitive deﬁcits were not seen in the
recurrent seizure group, in agreement with the ﬁndings by
Weglage et al.17 Accordingly, as a matter of course, EEGs should
be evaluated both in the awake and sleep states. However, a
marked interindividual variability from one child to another and
from one day to another has been shown.7 Further investigation
will be needed to clarify this point.CBZ sometimes exacerbates EEG abnormalities and behavioral/
cognitive impairment. However, patients in the recurrence group
did not show behavioral/cognitive impairments. In addition, the
frequency of paroxysmal EEG abnormalities decreased without
discontinuation of CBZ in the recurrence group. Moreover, the
spike frequency in the patient treated by VPA increased in a similar
manner to that seen in the patients treated by CBZ. Although the
effect of CBZ could not be excluded, the effect of CBZ does not
account for the worsening EEG in our recurrent cases.
Extended periods of frontal EEG focus suggested a higher risk
for developing atypical clinical features in our previous study.9
However, there was no difference in the periods of frontal EEG
focus between the recurrence and isolated groups in the present
study. Neither group showed cognitive/behavioral impairments.
This might be the reason why there was no difference with the
periods of frontal EEG focus. Otherwise, these ﬁndings suggest
that extended periods of frontal EEG focus affect mainly cognitive/
behavioral disturbance, not mainly seizure recurrence. However,
the occurrence of an EEG focus in the frontal region was
signiﬁcantly higher in the recurrence group than in the isolated
group in this study. In our previous study, the presence of a frontal
paroxysmal EEG abnormality was found to be correlated with
subsequent development of epilepsy in FS.20 These ﬁndings
suggest that a frontal EEG focus may be associated with seizure
recurrence in RE. However, the pathophysiology of a frontal EEG
focus remains unclear. Further investigation will be needed to
clarify this point.
Spike activity such as high frequency may be related to
maturation, which is different between the two groups.21
Similarly, the present study suggests that a high frequency of
paroxysmal discharges may be related to seizure recurrence. With
a thorough assessment of seizure recurrence and serial EEG
recordings from the onset of RE, potential predictors or risk factors
for seizure recurrence were identiﬁed. However, the present study
had some limitations such as its small sample size. The
assumptions have to be examined by a careful prospective study
of a large population of RE patients.
5. Conclusion
The present study showed that the presence of extended
periods of a high frequency of paroxysmal EEG abnormalities
(more than 6 months after onset) and an abundance of awake
interictal abnormalities were associated with seizure recurrence.
Serially recorded EEG markers may predict recurrent/isolated
seizures in children with RE.
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